abeglutide glp-1 Agonists: A Comprehensive Overview GLP-1 Weight Loss Treatment (Semaglutide)

Funding This paper was supported by San Matteo Hospital Foundation, Internal Medicine research fundings, PRIN2017. Publishers note All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

That does not mean the article should create blend claims or variant-specific SEO targeting

Efficacy and safety of canagliflozin as add-on therapy to a glucagon-like peptide-1 receptor agonist in Japanese patients with type 2 diabetes mellitus: a 52-week, open-label, phase IV study

doi: 10.1038/nature04250 77 IannuzzoF.BasileG